CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 2, Randomized, Multicenter, Open-label Neoadjuvant Study Evaluating Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07102381
- Title field or adapter rule
- {'original_value': 'A Phase 2, Randomized, Multicenter, Open-label Neoadjuvant Study Evaluating Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer', 'source_field': 'protocolSection.identificationModule.officialTitle'}
- Ingested At
- 2026-10-31T23:27:30.652016+00:00
- Published At
- 2026-10-29T00:00:00+00:00
- Record Updated At
- 2026-10-29
- Source Retrieved At
- 2026-10-31T22:18:24.976182+00:00
- Timestamp Basis
- ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
- Date limitation
- ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["HER2-positive Breast Cancer", "Breast Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-29", "type": "ACTUAL"}- protocolSection.identificationModule.nctId
"NCT07102381"- protocolSection.identificationModule.officialTitle
"A Phase 2, Randomized, Multicenter, Open-label Neoadjuvant Study Evaluating Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct
null
Study condition terms
Interventions recorded in this study
- {'armGroupLabels': ['Zanidatamab with docetaxel and carboplatin', 'Zanidatamab with paclitaxel'], 'description': 'Administered intravenously (IV)', 'name': 'Zanidatamab', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Zanidatamab with paclitaxel'], 'description': 'Administered intravenously (IV)', 'name': 'Paclitaxel', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Trastuzumab and pertuzumab with docetaxel and carboplatin', 'Zanidatamab with docetaxel and carboplatin'], 'description': 'Administered intravenously (IV)', 'name': 'Docetaxel', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Trastuzumab and pertuzumab with docetaxel and carboplatin', 'Zanidatamab with docetaxel and carboplatin'], 'description': 'Administered intravenously (IV)', 'name': 'Carboplatin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Trastuzumab and pertuzumab with docetaxel and carboplatin'], 'description': 'Administered intravenously (IV)', 'name': 'Trastuzumab', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
- {'armGroupLabels': ['Trastuzumab and pertuzumab with docetaxel and carboplatin'], 'description': 'Administered intravenously (IV)', 'name': 'Pertuzumab', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
An intervention appearing in a study record does not establish an effect or an approved use.
Drug names recorded in this source
A recorded drug name is not by itself an indication or a condition-specific relationship.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.